in

AIDPHS 2025

Oct 23, 2025 | Boston, USA

Oct23

AIDPHS 2025
berryprofessionals.com

When:

Why Attend?

  • Join senior experts from Pfizer, AstraZeneca, Moderna, Merck, Johnson & Johnson, and more
  • Explore keynotes and panels on GenAI in clinical trials, GPT agents, LLMs, and longitudinal data
  • Gain insights on scaling AI across the drug development lifecycle
  • Network with data science, analytics, and innovation leaders shaping the future of healthcare
  • Benefit from early-bird pricing before June 2025

Key Topics

  • Leveraging Data Across the Clinical Development Lifecycle
  • Scaling AI for Drug Discovery and R&D
  • LLMs and Agentive AI in Pharma
  • GenAI in Clinical Trials
  • Regulated Data & AI Capabilities
  • Omnichannel and Patient Analytics
  • Real-World Evidence (RWE) and Data Challenges
  • Digital Health and MedTech Innovation

Who Should Attend?

  • Pharma Data Scientists and Engineers
  • Healthcare AI Researchers
  • Digital Health Leaders
  • Biotech and MedTech Innovators
  • RWE, Clinical Trials, and Regulatory Experts

Notable Speakers Include

  • Yan Hu, Director-Data Science, Novo Nordisk
  • Valerie Alleger, Senior Director, Global Data Science, Johnson & Johnson
  • Eran Nevo, Sr. Director, Data & AI, Teva Pharmaceuticals
  • Gunjan Aggarwal, Executive Director – Insights, Novartis
  • Victoria Gamerman, Global Head of Digital Transformation, Boehringer Ingelheim
  • Naveed Afzal, Head of Data Science, Takeda
  • Ali Soltani Tehrani, Associate Director of Data Science, AstraZeneca
  • Vitaly Doban, VP, Head of Data & Insights Generation, Ipsen
  • Adam Mico, Principal, Data Strategist, Moderna
  • Amir Tahmasebi, Director, CV & NLP, BD
  • Kunal Rama, Director – Data Enablement, Pfizer
  • Dana Vuzman, Sr Director, Data Engineering, Novo Nordisk
  • Harsh Singh, Director, Data Analytics & AI, Merck

Explore more AI conferences and events on the AIPressRoom Events page.

AAIEC 2025

DMSIS 2025